ORBITAL NON-HODGKIN’S LYMPHOMAS
https://doi.org/10.17650/2222-1468-2012-0-2-45-47
Abstract
The results of the comprehensive diagnosis (computed tomography, thermography, fine needle aspiration cytology, exploratory orbitotomy with histological and immunohistochemical studies of orbital tumor biopsy specimens) and treatment (polychemotherapy and teleradiotherapy) were analyzed in 66 patients (80 orbital sockets) with malignant (non-Hodgkin’s) lymphomas of the orbit in the period 2008–2011.
About the Authors
S. V. SaakyanRussian Federation
V. V. Valsky
Russian Federation
Ye. B. Myakoshina
Russian Federation
O. G. Panteleyeva
Russian Federation
M. G. Zhiltsova
Russian Federation
I. P. Khoroshilova‑Maslova
Russian Federation
G. P. Zakharova
Russian Federation
References
1. Бровкина А.Ф. Офтальмоонкология. М.: Медицина, 2002. 421 с.
2. Гришина Е.Е. Злокачественные лимфомы орбиты: лечение с позиции офтальмолога. Сб-к научн. трудов межд. симпозиума «Заболевания, опухоли и травматические повреждения орбиты», 2005. С. 192–196.
3. Гришина Е.Е., Нечеснюк С.Ю., Лернер М.Ю. Неходжкинские лимфомы орбиты: клинико-морфологические параллели. Сб-к научн. трудов межд. симпозиума «Заболевания, опухоли и травматические повреждения орбиты», 2005. С. 78–83.
4. Саакян С.В., Мякошина Е.Б., Хорошилова-Маслова И.П., Захарова Г.П., Жильцова М.Г. Злокачественные (неходжкинские) лимфомы орбиты по обращаемости. Мат. научн.практ. конф., посвящ. 80-летию НИИ нейрохирургии им. акад. Н.Н. Бурденко РАМН. М., 2012. С. 86–87.
5. Cahill M., Barnes C., Moriarty P. et аl. Ocular adnexal lymphoma- comparison of MALT lymphoma with other histological types. Br J Ophthalmol 1999;83:742–7.
6. Canellos G.P., Lister T.A., Sklar J.L. General aspects of extranodal lymphoma. In The Lymphomas. W.B. Saunders Company, 1997. P. 450–478.
7. Conconi A., Martinelli G., Thieblemont C. et al. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood 2003;102(8):2741–5.
8. Coupland S.E. Lymphoproliferative lesions of ocular adnexa. Differential diagnostic guidelines. Opthalmologe 2004;101(92):197–215.
9. Harris N.L., Jaffe E.S., Diebold J. et al. The World Health Organization classification of neoplastic diseases of hematopoetic and lymphoid tissues. Ann Oncology 1999;10:1419–33.
10. Hasegawa M., Kojima M., Shioya M. et аl. Treatment results of radiotherapy for malignant lymphoma of orbit and histopathologic review according to the WHO classification. Int J Radiat Oncol Biol Phys 2003;57:172–6.
11. Lee S.W., Suh C.O., Kim G.E. et аl. Role of radiotherapy for primary orbital lymphoma. Am J Clin Oncol 2002;25(3):261–5.
12. Malek S.N., Hatfield A.J., Flinn I.W. MALT Lymphomas. Curr Treat Options Oncol 2003;4:269–79.
13. Schick U., Lermen O., Unsold R. et al. Treatment of primary orbital lymphomas. Eur J Haematol 2004;72(3):186–92.
14. Stafford S.L., Kozelsky T.F., Garrity J.A. et al. Orbital lymphoma: radiotherapy outcome and complications. Radiother Oncol 2001;59(2):139–44.
Review
For citations:
Saakyan S.V., Valsky V.V., Myakoshina Ye.B., Panteleyeva O.G., Zhiltsova M.G., Khoroshilova‑Maslova I.P., Zakharova G.P. ORBITAL NON-HODGKIN’S LYMPHOMAS. Head and Neck Tumors (HNT). 2012;(2):45-47. (In Russ.) https://doi.org/10.17650/2222-1468-2012-0-2-45-47